Hear dermatologists Dr. Kristina Duffin, MD, MS, Professor and Chair of the Department of Dermatology at the University of Utah and Dr. Joel Gelfand, MD, MSCE, FAAD, Director, Psoriasis & Phototherapy Treatment Center at Penn, discuss the Light Treatment Effectiveness (LITE) Study and the data presented at the 2024 AAD Annual Meeting.

The LITE Study is funded with support from the Patient-Centered Outcomes Research Institute (PCORI), an independent research institute authorized by Congress to fund comparative clinical effectiveness research that engages patients and other stakeholders in the research process. This study also benefited from the Daavlin Company’s contribution of the phototherapy machines on behalf of this study.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear gastroenterologist Dr. Lisa Malter, Professor at the Department of Medicine at NYU Grossman School of Medicine, discuss the intersection between psoriasis and IBD.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear rheumatologist Dr. Lihi Eder from the University of Toronto discuss diagnostic biomarkers and the use of imaging to diagnose psoriatic arthritis.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Hear Dr. Ron Prussick, from the Washington Dermatology Center, discuss the importance of diet in patients living with psoriasis.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Can accountability and gamification improve treatment adherence? Hear Dr. Steven Feldman, Professor at Wake Forest University School of Medicine, discuss this and more.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Patients living with psoriasis may have an increased risk of certain infections, but also certain infections can trigger or exacerbate psoriasis symptoms. Listen to dermatologist, Dr. Seth Forman, and his patient Katie Chambers as they discuss the intersection of infection and PsO.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Although rare, erythrodermic psoriasis can be life-threatening. Listen to Dr. Mio Nakamura, Assistant Professor of Dermatology at the University of Michigan discusses this severe variant of psoriasis vulgaris.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.

Hear Dr. Mona Shahriari, M.D., Assistant Clinical Professor of Dermatology at Yale University School of Medicine, the Associate Director of Clinical Trials at CCD Research and a senior editor for the Journal of Psoriasis and Psoriatic Arthritis, discuss discuss diagnosis and managing psoriasis in people with skin of color.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from AbbVie and Novartis.